A detailed history of Sg Americas Securities, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 25,619 shares of AQST stock, worth $90,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,619
Previous 16,123 58.9%
Holding current value
$90,435
Previous $42,000 204.76%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$2.4 - $5.09 $22,790 - $48,334
9,496 Added 58.9%
25,619 $128,000
Q2 2024

Jul 12, 2024

BUY
$2.31 - $4.5 $8,080 - $15,741
3,498 Added 27.71%
16,123 $42,000
Q1 2024

May 06, 2024

BUY
$2.01 - $6.09 $25,376 - $76,886
12,625 New
12,625 $54,000
Q3 2020

Nov 09, 2020

SELL
$4.12 - $9.09 $44,578 - $98,353
-10,820 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$1.84 - $6.44 $19,908 - $69,680
10,820 New
10,820 $53,000

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $188M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.